PVCT - PROVECTUS BIOPHARMACEUTICALS, INC.
0.0956
0.006 5.858%
Share volume: 3,944
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$0.09
0.01
0.06%
Summary score
43%
Profitability
35%
Dept financing
50%
Liquidity
5%
Performance
60%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2020 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-175.58%
Return on sales
-8579.92%
Return on invested capital
0%
Total debt ratio
735.74%
Debt ratio change over timeo
0%
Current Ratio
0.13%
Quick Ratio
0%
Cash Position Ratio
0.04%
Short-term ratios 31-Dec-2023 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-175.58%
Return on sales
-8579.92%
Return on invested capital
0%
Total debt ratio
735.74%
Debt ratio change over timeo
0%
Current Ratio
0.13%
Quick Ratio
0%
Cash Position Ratio
0.04%
Last quarter ratios 31-Dec-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-232%
Return on sales
-16288.98%
Return on invested capital
0%
Total debt ratio
693.62%
Debt ratio change over time
0%
Current Ratio
0.14%
Quick Ratio
0%
Cash Position Ratio
0.04%
Performance ratios (change over 4 years) 31-Dec-2020 - 31-Dec-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | PVCT | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 14.82% | 9.25% | 0% |
| Return on assets | -175.58% | 4.21% | 3.01% | 0% |
| Return on sales | -8579.92% | 27.61% | 25.13% | 0% |
| Return on invested capital | 0% | 8.25% | 9.21% | 0% |
| Profitability | 0% | 97% | 81% | 0% |
| Total debt ratio | 735.74% | 81.46% | 59.72% | 0% |
| Debt ratio change over time | 0% | -9.8% | -49.67% | 0% |
| Dept financing | 50% | 3% | 2% | 0% |
| Current Ratio | 0.13% | 1.22% | 1.1% | 0% |
| Quick Ratio | 0% | 0.94% | 0.86% | 0% |
| Cash Position Ratio | 0.04% | 0.13% | 0.46% | 0% |
| Liquididy | 4% | 55% | 75% | 0% |
| Short-term ratios | PVCT | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -175.58% | 4.34% | 2.26% | 0% |
| Return on sales | -8579.92% | 28.22% | 23.48% | 0% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 34% | 0% |
| Total debt ratio | 735.74% | 81.06% | 60.18% | 0% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 50% | 3% | 2% | 0% |
| Current Ratio | 0.13% | 1.22% | 1.1% | 0% |
| Quick Ratio | 0% | 0.94% | 0.86% | 0% |
| Cash Position Ratio | 0.04% | 0.13% | 0.46% | 0% |
| Liquididy | 5% | 57% | 70% | 0% |
